Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel
Caterpillar fungus believed to cure ailments
Scientists discover fungus has anti-inflammatory properties

A new study, published in the journal RNA, has shed light on the “golden worm” or “Tibetan mushroom” thought by locals in Tibet to cure everything from cancer to asthma to erectile dysfunction.

For a Tibetan mushroom to form, a fungus must attach itself to a moth larva burrowed in the soil. It will then slowly consume the host from within, taking over its brain and making the young caterpillar move to position which the fungus can grow and spore again.

The parasite is called cordyceps and produces the chemical cordycepin which scientists now believe has anti-inflammatory properties.

Study co-author Cornelia H. de Moor, of the University of Nottingham, explained: "Inflammation is normally a beneficial response to a wound or infection, but in diseases like asthma it happens too fast and to too high of an extent. When cordycepin is present, it inhibits that response strongly."

The chemical does this in a way not previously seen: at the mRNA stage, where it inhibits polyadenylation. This means it stops swelling at the genetic cellular level - a novel anti-inflammatory approach that could lead to new drugs for cancer, asthma, diabetes, rheumatoid arthritis, and cardiovascular-disease patients who don't respond well to current medications.

However, these new drugs may be a long way off. The science of parasitic fungi is still in its early stages, and no medicine currently available utilises cordycepin as an anti-inflammatory. The only way a patient could gain its benefits would be by consuming wild-harvested mushrooms.

"I can't recommend taking wild-harvested medications," warned de Moor. "Each sample could have a completely different dose, and there are mushrooms where a single bite will kill you."

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'